Pharmacology and Toxicology
Recent Deposits
-
Adrenergic stimulation of HK-2 proximal tubular cells in hyperglycaemic conditions
One of the most commonly associated complications of Diabetes Mellitus is nephropathy, with one in five diabetics sustaining renal injury over their lives. Renal denervation has been shown to decrease systemic blood pressure ... -
The Cytotoxicity and Action of Curcumin Derivatives against Fn14+ Triple Negative Breast Cancer through repression of NF-κB p65
Triple negative breast cancer (TNBC) is an aggressive subtype of the disease which lacks options for targeted systemic therapies due to a lack of actionable clinical targets. Molecular analysis has revealed that Fn14, a ... -
The Cytotoxic Mechanism of RL112 in Ovarian Cancer Cells
Background: Ovarian cancer is the most lethal gynecological malignancy among women, and there is limited treatment. The search for effective therapies for ovarian cancer has led to the emergence of natural compounds such ... -
Design, Synthesis and Structure-Activity Relationships of Some Novel Thiol Peroxidase Mimics
This study was designed to examine the structure activity relationships (SARs) between thiol peroxidase (TPx) activity, cytotoxicity and anti-oxidant versus pro-oxidant properties for homologous series of phenyl alkyl ... -
How Bone Marrow Mesenchymal Stem Cells Influence the Metastasis of Breast Cancer
Mesenchymal stem cells (MSCs) are multipotent non-haematopoietic cells primarily originating from within the bone marrow. Physiologically they aid in the process of wound healing. However, MSCs are also recruited by cancer ... -
Anticancer Potential of Novel Curcumin Analogues towards Hormone-Refractory Prostate Cancer
Prostate cancer, a hormonally driven and dependent malignancy, is a leading cause of cancer-related deaths in men. Hormonal therapy including surgical castration and medical/chemical castration to cause regression of ... -
Low dose inhaled carbon monoxide and cardiac ischaemia reperfusion injury
INTRODUCTION Low dose carbon monoxide (CO), a byproduct of heme oxygenase, has been shown to cause vasodilatation, modify platelet adherence, reduce inflammation and inhibit apoptosis. Cardiac ischaemia-reperfusion (IR) ... -
Targeting the Anaplastic Lymphoma Kinase (ALK) and the Insulin-like Growth Factor Receptor 1 (IGF1R) in crizotinib resistant lung cancer cells
Non-small lung cancer (NSCLC) accounts for approximately 85% of all lung cancer-related deaths worldwide. Historically, platinum-based chemotherapy regimens have been the first-line treatment for advanced NSCLC, however ... -
The effect of vestibular lesions on the hippocampal cholinergic system
Bilateral vestibular loss (BVL) produces profound behavioural changes, some of which do not appear to be directly associated with the acute loss of vestibular information, such as hyperlocomotion and spatial memory ... -
The use of combination tyrosine kinase inhibitors for the treatment of glioblastoma multiforme
Glioblastoma is the most common primary brain tumor which has a median survival of only 14.6 months. The central nervous system localization, heterogeneity of the cells and resistance to treatment constitute a significant ... -
Comparison of Spironolactone versus Amlodipine in Hypertensive Cardiorenal Pathology
Hypertension is endemic worldwide, afflicting up to 40% of the global population over the age of 25. Haemodynamic stretch stress from raised blood pressure is a driver for organ damage in the heart and kidney, contributing ... -
Identification of differentially expressed genes in response to treatment with RL71 and SMA-RL71 in triple negative breast cancer cell lines
Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype characterised by a poor outcome when compared to other breast cancers. The lack of safe and targeted therapy for TNBC promotes the need for the ... -
Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery
ABSTRACT The oral route is the preferred mode of drug administration due to its non-invasive nature, economical benefits, and the potential to improve patients’ quality of life. Oral administration of anticancer agents ... -
A Novel Mechanism for Nicotinic Acetylcholine Receptor Antagonist-Induced Cancer Cell Cytotoxicity
Nicotinic acetylcholine receptors (nAChRs) are common ligand-activated neurotransmitter receptors located throughout the body. The up-regulation of nAChRs subunits has been observed in a number of cancer types; while current ... -
Using Raloxifene and the Curcumin Derivative, RL91, for the Treatment of Castrate Resistant Prostate Cancer
Prostate cancer is the second most diagnosed cancer worldwide and accounts for 15% of all cancer in men. Localised prostate cancer, contained within the capsule of the prostate gland, is effectively treated with surgery, ... -
Elucidation of the Anticancer Mechanism of Action of a Novel Di-Palladium Helicate
Metal-based therapeutics are utilised in up to 50% of anticancer treatments. However, the therapeutic use of these agents is limited by the lack of target specificity and the development of patient resistance to therapy. ... -
The Effect of Photoactivation on the Mechanism of Action of tDodSNO
Since the discovery and identification of nitric oxide (NO) in vivo more than 30 years ago, a wealth of knowledge has been collected regarding its biological action. More recently, NO has been shown to be a valuable ... -
In Vitro Analysis for the use of Honey Bee Products in the Treatment of Metastatic Prostate Cancer
The prognosis for men diagnosed with advanced metastatic prostate cancer is poor. A low five-year survival rate of 28% highlights the ongoing need for improved treatment options, with attention to a reduction in prostate ... -
Heterocyclic Cyclohexanone Curcumin Analogues Inhibit Growth of Ovarian Cancer Cells, in-vitro
Background: Ovarian cancer is the most lethal gynaecological cancer in women. Nearly a quarter of a million women are newly diagnosed globally, with up to 140,200 lives lost annually. The high mortality is attributed to ... -
SMA-raloxifene for the management of castrate-resistant prostate cancer
Castrate-resistant prostate cancer (CRPC) has a poor prognosis, and these tumours are refractory to conventional androgen deprivation therapy. In addition to androgen, oestrogen alone or combined with androgen induces ...